Composition
- Active ingredients
- GRISEOFULVIN, MICROCRYSTALLINE 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- GRISEOFULVIN, MICROCRYSTALLINE 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
- GRISEOFULVIN, MICROCRYSTALLINE 125MG · TabletANDA062279-001 · Discontinued
- GRISEOFULVIN, MICROCRYSTALLINE 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SuspensionNDA050448-001 · Discontinued
- GRISEOFULVIN, MICROCRYSTALLINE 250MG · TabletANDA060618-002 · Discontinued
- GRISEOFULVIN, MICROCRYSTALLINE 500MG · TabletANDA060618-003 · Discontinued
- GRISEOFULVIN, MICROCRYSTALLINE 125MG · TabletANDA060618-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA062279.
At a glance
- Brand name
- Grifulvin V
- Active substance
- griseofulvin, microcrystalline
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Valeant Luxembourg
- Status
- Discontinued
- FDA approval
- 2 Jun 1980
- Application
- ANDA062279-002